Weight-loss drugs may reduce breast cancer risk by 30%

Weight-loss drugs may reduce the risk of developing or dying from breast cancer by up to 30%, according to three studies presented at a major oncology conference. These findings suggest that the drugs, already used by millions for obesity treatment, could be integrated into cancer prevention and treatment strategies.

Read the full story at The Guardian AU→